Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CETP阻害薬及びHMG-CoA還元酵素阻害薬を含有する剤形
Document Type and Number:
Japanese Patent JP2006512359
Kind Code:
A
Abstract:
A dosage form comprises (1) a solid amorphous dispersion comprising a cholesterol ester transfer protein inhibitor and an acidic concentration-enhancing polymer and (2) an HMG-CoA reductase inhibitor. The solid amorphous dispersion and the HMG-CoA reductase inhibitor are combined in the dosage form so that the solid amorphous dispersion and the HMG-CoA reductase inhibitor are substantially separate from one another in the dosage form.

Inventors:
Friesen, Dwayne Thomas
Lorenz, Douglas Alan
Rion, David Keith
Hancock, Bruno Casper
McDermott, Timothy Joseph
Shanker, Rabi Mysore
Application Number:
JP2004561902A
Publication Date:
April 13, 2006
Filing Date:
December 12, 2003
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Pfizer Products Inc.
International Classes:
A61K45/06; A61K9/08; A61K9/14; A61K9/16; A61K9/20; A61K9/24; A61K9/48; A61K31/00; A61K31/40; A61K31/4706; A61K47/38; A61P3/06; A61P43/00
Domestic Patent References:
JP2002532409A2002-10-02
Foreign References:
WO2000038722A12000-07-06
WO2002100394A12002-12-19
US6310075B12001-10-30
WO2002013797A22002-02-21
WO2002011710A22002-02-14
WO2001093860A12001-12-13
Attorney, Agent or Firm:
Atsushi Aoki
Takashi Ishida
Fukumoto product
Tetsuji Koga
Kazumi Nakamura
Masaya Nishiyama